Investigational drug · Phase 3
RTX-GRT7039
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Osteoarthritis.
Phase 3Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
0 still active
All registered trials
3
Any phase or sponsor naming "RTX-GRT7039"
First trial start
2022
Aug 26, 2022
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "RTX-GRT7039", any sponsor or status.
Conditions studied
As listed on its trial records.
- Osteoarthritis
Approved drugs for the same conditions: Osteoarthritis
Largest trials
Live from ClinicalTrials.gov: studies naming "RTX-GRT7039" as an intervention, largest first.
- Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the KneePivotal-lookingCompleted
Grünenthal GmbHIndustry
NCT05377489 · 714 participants · Start Sep 15, 2022 · Primary completion May 15, 2025
Drug: RTX-GRT7039 · For: Osteoarthritis
Sites: Glendale, Arizona; Phoenix, Arizona; Anaheim, California · 96 sites in all
- Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee OsteoarthritisPivotal-lookingCompleted
Grünenthal GmbHIndustry
NCT05248386 · 469 participants · Start Aug 26, 2022 · Primary completion Nov 18, 2024
Drug: RTX-GRT7039; Placebo · For: Osteoarthritis
Sites: Victoria, Canada; Brampton, Canada; Mississauga, Canada · 103 sites in all
- Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the KneePivotal-lookingCompleted
Grünenthal GmbHIndustry
NCT05449132 · 466 participants · Start Sep 26, 2022 · Primary completion Aug 15, 2024
Drug: RTX-GRT7039; Placebo · For: Osteoarthritis
Sites: Birmingham, Alabama; Glendale, Arizona; Phoenix, Arizona · 81 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Efficacy and safety of the TRPV1 agonist RTX-GRT7039 in patients with pain associated with knee osteoarthritis: Results from a phase 3, randomised, placebo-controlled trial.
Berenbaum F, Latourte A, Kivitz A, et al. · Osteoarthritis Cartilage 2026
Also in development for Osteoarthritis
- EloralintideLY3841136Phase 313 trials
Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2
- EtoricoxibPhase 34 trials
Laboratorios Silanes S.A. de C.V. · Gout Arthritis, Gout Attack, Acute Low-back Pain
- [StroMedPhase 23 trials
VivaTech International, Inc. · Osteoarthritis
- mesenchymal stem cellumbilical cord derived MSCsPhase 23 trials
Cell Energy Life Sciences Group Co. LTD · AIDS, Ischemic Heart Disease, Osteoarthritis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.